Login to Your Account



Launching Benlysta

Looking for the Reward, Living with the Risk

By Tom Wall


Friday, April 29, 2011
On March 9, 2011 – 56 years after the FDA OK'd the last drugs to treat systemic lupus erythematosus (SLE) – the agency approved Benlysta (belimumab).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription